follow us in feedly
MicroCapNewsDaily
  • Mining
  • Cannabis
  • Energy
  • Tech
  • Health
  • Biotech
  • Price Charts

Join Our Community

Facebook

Twitter

RSS

      Home2023January

      Month: January 2023

      No Picture
      Energy

      Is SPDR S&P Oil & Gas Exploration & Production ETF (XOP) a Strong ETF Right Now?

      Jan 3 MicroCapNewsDaily
      Launched on 06/19/2006, the SPDR S&P Oil & Gas Exploration & Production ETF (XOP) is a smart beta exchange traded fund offering broad exposure to the Energy ETFs category of the market. What Are Smart more...
      No Picture
      Biotech

      ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR

      Jan 2 MicroCapNewsDaily
      ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR PR Newswire NEW YORK , Jan. 2, 2023 /PRNewswire/ more...
      No Picture
      Biotech

      7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

      Jan 2 MicroCapNewsDaily
      Los Angeles, California–(Newsfile Corp. – January 2, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eiger BioPharmaceuticals, Inc. (“Eiger” or “the Company”) more...
      No Picture
      Cannabis

      ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NewAge Inc. Investors with Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm – NBEV, NBEVQ

      Jan 1 MicroCapNewsDaily
      New York, New York–(Newsfile Corp. – January 1, 2023) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NewAge, Inc. (NASDAQ: NBEV) (OTC: NBEVQ) between January 18, 2018 more...
      No Picture
      Biotech

      BLRX NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

      Jan 1 MicroCapNewsDaily
      New York, New York–(Newsfile Corp. – January 1, 2023) – WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential civil securities claims on behalf of shareholders of BioLineRx Ltd. more...
      No Picture
      Biotech

      EYEPOINT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options

      Jan 1 MicroCapNewsDaily
      EYEPOINT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK , Jan. 1, 2023 /PRNewswire/ more...

      Posts navigation

      « 1 … 7 8

      Get Hot Stock Alerts Delivered to Your Inbox

      GET ALERTS
      Privacy

      Latest News

      • BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel

        Jan 5 MicroCapNewsDaily
        January 5, 2023
        The Class Action Seeks to Recover Damages on Shareholders’ Behalf SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces t more...
      • Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023

        Jan 5 MicroCapNewsDaily
        January 5, 2023
        – Determination of Recommended Phase 2 Dose and Start of Phase 2 in 1Q 2023 for Oral Fadraciclib – – 2/3 Partial Responses in Lymphoma and 11/15 Stable Disease in Advanced Solid Tu more...
      • CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event

        Jan 5 MicroCapNewsDaily
        January 5, 2023
        CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event PR Newswire Live video webcast on more...
      • Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

        Jan 5 MicroCapNewsDaily
        January 5, 2023
        LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical more...
      • Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate

        Jan 5 MicroCapNewsDaily
        January 5, 2023
        POSH-MAP and PORT-MAP investigator-sponsored trials to evaluate ability of ACER-801 (osanetant) to reduce hot flashes and as neoadjuvant therapy in men with prostate cancer NEWTON, Mass., Jan more...
      • MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

        Jan 5 MicroCapNewsDaily
        January 5, 2023
        Los Angeles, California--(Newsfile Corp. - January 5, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eiger more...
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2023 | 244 Fifth Avenue, Suite N-249 New York, N.Y. 10001 USA | 1-866-773-3540

      Copyright © 2023 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      244 Fifth Avenue, Suite N-249 New York, N.Y. 10001 USA | 1-866-773-3540